Tri Murti Andayani

Potential Cost Savings From Chemotherapy-Induced Febrile Neutropenia With Biosimilar Filgrastim and Expanded Access to Targeted Antineoplastic Treatment Across the European Union G5 Countries: A Simulation Study

Diana Sun, Tri Murti Andayani, Ahmed E. Altyar et al. · Clinical Therapeutics · 2015 · 55 citations

Medicine, Oncology, Pharmacoeconomics +13

The Description of Medication Adherence for Patients of Diabetes Mellitus Type 2 in Public Health Center Yogyakarta

Nur Rasdianah, Suwaldi Martodiharjo, Tri Murti Andayani et al. · Indonesian Journal of Clinical Pharmacy · 2016 · 37 citations · Full text

Medicine, Pharmacotherapy, Diabetology +16

Comparison of Real Cost Versus the Indonesian Case Base Groups (INZ-CBGs) Tariff Rates Among Patients of High- Incidence Cancers Under the National Health Insurance Scheme

Satibi Satibi, Tri Murti Andayani, Dwi Endarti et al. · Asian Pacific Journal of Cancer Prevention · 2019 · 23 citations · Full text

Health Professions, Health Policy, Insurance +17

ASSESSING THE IMPACT OF COMPLICATIONS ON THE DIRECT MEDICAL COSTS OF TYPE 2 DIABETES MELLITUS OUTPATIENTS

Tri Murti Andayani, Mohamed Izham, Mohamed Ibrahim · 2010 · 17 citations

Medicine, Internal Medicine, Pharmacoeconomics +15

Hubungan Tingkat Pengetahuan terhadap Outcome Klinik Pasien Diabetes Melitus Tipe 2

Laksmy Anggun Larasati, Tri Murti Andayani, Susi Ari Kristina · JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) · 2019 · 14 citations · Full text

Medicine, Internal Medicine, Chronic Illness Self-management +15